Tosoh has decided to increase its production capacity for separation and purification agents and build new manufacturing equipment at its Yokkaichi Plant (Yokkaichi City, Mie Prefecture).
Separation and purification agents, one of the main products of our Bioscience Division, are used in the manufacturing process of biopharmaceuticals. In addition to the mainstay antibody drugs, the biopharmaceutical market is expected to see further growth with the emergence of new fields such as nucleic acid drugs and gene therapy drugs. In order to respond to strong demand due to market growth, we will build new manufacturing equipment at the Yokkaichi Plant and increase capacity. Additionally, by decentralizing manufacturing and storage locations, we will build a strong and stable supply system from the perspective of business continuity planning (BCP).
Through this plan, we will continue to expand our bioscience business by responding to growing demand in a timely manner and expanding our lineup of related products.